News

Juvenescence & the Buck Institute announce a new joint venture with the formation of Selah Therapeutics Limited (“Selah”). Selah focuses on developing ketone-based therapies to treat heart failure & other...

Morphoceuticals Inc., a portfolio company of Juvenescence Ltd., hailed the results of a long-term study published by its founders in Science Advances showing the successful regeneration of limbs in Xenopus laevis (African clawed frog)....